NCT02998619View on ClinicalTrials.gov

Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

November 11, 2017

Study Completion Date

June 19, 2018

Conditions
Prostatic Neoplasms BenignRadiotherapy Side EffectLymph Node Disease
Interventions
RADIATION

Radiotherapy

Radiation to prostate/seminal vesicles including pelvic lymph nodes Postoperative radiation to prostate bed including pelvic lymph nodes

Trial Locations (1)

7000

Kantonsspital Graubuenden, Chur

All Listed Sponsors
lead

Kantonsspital Graubuenden

OTHER

NCT02998619 - Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis | Biotech Hunter | Biotech Hunter